Business Description
Achieve Life Sciences Inc
NAICS : 325413
SIC : 2835
ISIN : US0044682039
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.36 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.31 | |||||
Debt-to-EBITDA | -0.33 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 36.7 | |||||
3-Year EPS without NRI Growth Rate | 35.2 | |||||
3-Year FCF Growth Rate | 37.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 23.41 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 13.78 | |||||
9-Day RSI | 23.13 | |||||
14-Day RSI | 30.54 | |||||
6-1 Month Momentum % | -6.96 | |||||
12-1 Month Momentum % | 30.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.78 | |||||
Quick Ratio | 6.78 | |||||
Cash Ratio | 6.39 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -51.3 | |||||
Shareholder Yield % | -42.49 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -131.03 | |||||
ROA % | -72.74 | |||||
ROIC % | -238.08 | |||||
ROC (Joel Greenblatt) % | -59867.06 | |||||
ROCE % | -93.96 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 4.14 | |||||
Price-to-Tangible-Book | 4.44 | |||||
EV-to-EBIT | -3.2 | |||||
EV-to-EBITDA | -3.22 | |||||
EV-to-FCF | -3.78 | |||||
Price-to-Net-Current-Asset-Value | 4.49 | |||||
Price-to-Net-Cash | 4.92 | |||||
Earnings Yield (Greenblatt) % | -31.27 | |||||
FCF Yield % | -18.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Achieve Life Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -1.015 | ||
Beta | 2.02 | ||
Volatility % | 47.31 | ||
14-Day RSI | 30.54 | ||
14-Day ATR (€) | 0.081997 | ||
20-Day SMA (€) | 4.0435 | ||
12-1 Month Momentum % | 30.19 | ||
52-Week Range (€) | 3.1 - 4.955 | ||
Shares Outstanding (Mil) | 34.39 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Achieve Life Sciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Achieve Life Sciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Achieve Life Sciences Inc Frequently Asked Questions
What is Achieve Life Sciences Inc(FRA:SP4P)'s stock price today?
When is next earnings date of Achieve Life Sciences Inc(FRA:SP4P)?
Does Achieve Life Sciences Inc(FRA:SP4P) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |